Companies · Other Health Care
NEW YORK · Other Health Care
Diligence memoA one-page analyst read on CDSI I Holding Company, Inc. — recommendation, valuation, rhythm, risks.→CDSI I Holding Company, Inc. looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
CDSI I Holding Company, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
CDSI I Holding Company, Inc. is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 97% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 17%.
Round size and date are reported; the stage label is inferred from round size (latest is Series D+ — a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 97% of sector peers (real $). Modeled value above 99% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #13 of 18.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Alere Inc. | Series D+ | $500.0M | $9.2B | 2.15× |
| ADMI Holdings LP | Series D+ | $367.6M | $8.5B | 1.98× |
| Liberty Dialysis Holdings, Inc. | Series D+ | $688.3M | $8.0B | 1.87× |
| Triangle Acquisition Holdings Inc. | Series D+ | $313.4M | $7.2B | 1.69× |
| MedSolutions Holdings, Inc. | Series D+ | $300.0M | $6.9B | 1.61× |
| Sbg Group Holdings, Inc. | Series D+ | $298.0M | $6.9B | 1.60× |
| Partners Solutions, Llc | Series D+ | $251.3M | $5.8B | 1.35× |
| Athletic Therapy Institute Holdings Llc | Series D+ | $225.8M | $5.2B | 1.21× |
| Millennium Lab Holdings, Inc. | Series D+ | $196.0M | $4.5B | 1.05× |
| PG-ACP Holdings, L.P. | Series D+ | $176.0M | $4.0B | 0.95× |
| Devicor Medical Products Group Llc | Series D+ | $151.5M | $3.5B | 0.81× |
| Remedi SeniorCare Holding Corp | Series D+ | $342.2M | $3.4B | 0.80× |
| CDSI I Holding Company, Inc. this company | Series D+ | $136.5M | $3.1B | 0.73× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series D+ | $136.5M | 2010-01-11 | $1.1B | $3.1B | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Robert Bergmann | — | 6 other | 2010-01 |
| Michael Schnabel | — | 4 other | 2010-01 |
| Bruce Pollack | — | 2 other | 2010-01 |
| Leif Murphy | — | 1 other | 2010-01 |
| George Attmore | — | — | 2010-01 |
| Jay Yalowitz | — | — | 2010-01 |
| Judy Lefkovitz | — | — | 2010-01 |
| Michael Zugay | — | — | 2010-01 |
CDSI I Holding Company, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Seafood Kitchen Holdings, LLC | Food & Beverage | Series D+ | $167.5M | $2.2B | network2 shared operators · same stage |
| Vantage Holdings, Inc. | Other Health Care | Series D+ | $137.6M | $3.2B | same sector · same stage |
| Nuvalent, Inc. | Other Health Care | Series D+ | $135.0M | $2.6B | same sector · same stage |
| Diplomat Pharmacy, Inc. | Other Health Care | Series D+ | $140.0M | $3.2B | same sector · same stage |
| Heska Corp | Other Health Care | Series D+ | $132.1M | $2.8B | same sector · same stage |
| Ember Management Aggregator, L.P. | Other Health Care | Series D+ | $129.9M | $1.8B | same sector · same stage |
| Hc Group Holdings Iii, Inc. | Other Health Care | Series D+ | $144.3M | $3.3B | same sector · same stage |
| Renovaro Inc. | Other Health Care | Series D+ | $123.3M | $1.2B | same sector · same stage |
See where CDSI I Holding Company, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at CDSI I Holding Company, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.